RE:RE:RE:RE:Technical analysisI understand KevinOleary. FDA dealys are common but it's been happening with the almost every aspects of their business in the past -- for example, look at the acne trial with UofMiami...it's been postponed numerous time.
For my part, I'd rather see them being more conservative on the timeline and make sure they set the expectations at the right level so that the investment community doesn't have too high expectations, no disappointment and ultimately will see some improvement on the whole process.
That's my take on this. Obviously, we can agree to disagree :)